Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

343.25 -4.58 (-1.32%)
Streaming Delayed Price Updated: 12:15 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,963
Open 345.28
Bid (Size) 343.09 (1)
Ask (Size) 343.26 (1)
Prev. Close 347.83
Today's Range 341.85 - 347.79
52wk Range 282.21 - 367.00
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in October
Growth catalysts lie ahead for both of these players. 
Via The Motley Fool

Performance

YTD
+20.01%
+20.01%
1 Month
-1.44%
-1.44%
3 Month
-1.24%
-1.24%
6 Month
+8.51%
+8.51%
1 Year
+15.41%
+15.41%

More News

Read More
Got $1,000? 2 No-Brainer Stocks to Buy
Via The Motley Fool
3 Magnificent Stocks That Are Screaming Buys in October
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Via The Motley Fool
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
This Is What Whales Are Betting On Vertex Pharmaceuticals
Via Benzinga
2 Brilliant Growth Stocks to Invest $2,000 in Right Now
Via The Motley Fool
5 Top Stocks for October
Via The Motley Fool
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
Via InvestorPlace
The Best Stocks to Invest $5,000 in Right Now
Via The Motley Fool
Why Editas Medicine Stock Is Soaring Today
Via The Motley Fool
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment
Via Investor's Business Daily
Exposures Product Safety
Price Over Earnings Overview: Vertex Pharmaceuticals
Via Benzinga
2 Healthcare Stocks That Could Make You Richer
Via The Motley Fool
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
Via InvestorPlace
Three Of Our Top Picks For Your Healthcare Portfolio
Via Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
Via InvestorPlace
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
Via The Motley Fool
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
Via Investor's Business Daily
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
Via The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.